Farther Finance Advisors LLC boosted its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 391.6% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,005 shares of the company’s stock after purchasing an additional 33,460 shares during the quarter. Farther Finance Advisors LLC’s holdings in Colgate-Palmolive were worth $4,361,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Diversify Advisory Services LLC bought a new stake in Colgate-Palmolive during the first quarter worth approximately $911,000. TD Asset Management Inc boosted its position in shares of Colgate-Palmolive by 2.4% in the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock valued at $103,969,000 after acquiring an additional 26,987 shares during the period. Empowered Funds LLC boosted its position in shares of Colgate-Palmolive by 277.3% in the first quarter. Empowered Funds LLC now owns 33,082 shares of the company’s stock valued at $2,979,000 after acquiring an additional 24,314 shares during the period. M&G Plc bought a new stake in shares of Colgate-Palmolive in the first quarter valued at approximately $3,812,000. Finally, Sei Investments Co. boosted its position in shares of Colgate-Palmolive by 41.5% in the first quarter. Sei Investments Co. now owns 598,639 shares of the company’s stock valued at $53,901,000 after acquiring an additional 175,445 shares during the period. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Stock Down 0.4 %
Shares of NYSE CL opened at $93.30 on Friday. The stock has a market cap of $76.23 billion, a PE ratio of 26.73, a PEG ratio of 3.38 and a beta of 0.40. The business has a fifty day moving average of $102.26 and a two-hundred day moving average of $98.19. Colgate-Palmolive has a 52-week low of $74.22 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.28 and a current ratio of 1.04.
Colgate-Palmolive Dividend Announcement
Analyst Ratings Changes
Several research firms have recently weighed in on CL. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their price objective for the company from $107.00 to $109.00 in a research report on Monday, September 9th. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research report on Monday, October 28th. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the company from $105.00 to $101.00 in a research note on Monday, October 28th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday. Finally, Bank of America upped their target price on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus price target of $105.11.
Get Our Latest Research Report on CL
Insider Activity at Colgate-Palmolive
In related news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock valued at $4,486,063 over the last ninety days. 0.34% of the stock is owned by insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- What Are the U.K. Market Holidays? How to Invest and Trade
- Battle of the Retailers: Who Comes Out on Top?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- What is the S&P 500 and How It is Distinct from Other Indexes
- MarketBeat Week in Review – 10/28 – 11/1
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.